Physician profile
Orlando Deffer
NPI 1588836621
$4,705.28
in general payments reported to CMS, 2019-2025
23 companies · $3,289 in 2025
The $3,289 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $41.22 · 2021: $201 · 2022: $107 · 2023: $321 · 2024: $476 · 2025: $3,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,335 · Travel and Lodging: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,335.07 |
| Travel and Lodging | $1,750.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,886.95 | 2023-2025 | General - Therapies, Emblem Mri S-Icd, Ingevity+ |
| Medtronic, INC. | $398.72 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Aquamantys(Tm) |
| Edwards Lifesciences Corporation | $192.74 | 2024 | Pascal |
| Novartis Pharmaceuticals Corporation | $189.77 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $167.43 | 2022-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $120.04 | 2022-2025 | Gallant, Aveir, Cardiomems |
| Biosense Webster, INC. | $119.44 | 2024-2025 | Carto 3 |
| Actelion Pharmaceuticals US, INC. | $92.87 | 2019-2021 | |
| Baxter Healthcare | $92.45 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.91 | 2019 | |
| Shockwave Medical, INC | $54.79 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $53.98 | 2019-2021 | |
| Biotronik INC. | $53.22 | 2024 | Acticor 7 Vr-T Dx |
| Pfizer INC. | $29.83 | 2019 | |
| Amarin Pharma, INC. | $29.36 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.17 | 2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $20.00 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $17.31 | 2021 | |
| Ge Healthcare | $16.18 | 2023 | |
| Scpharmaceuticals INC. | $16.16 | 2024 | |
| Abiomed | $15.11 | 2023 | Impella |
| Kowa Pharmaceuticals America, INC. | $14.56 | 2019 | |
| Medtronic Vascular, INC. | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orlando Deffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.